Pharmacologic treatment of acute pediatric methamphetamine toxicity

Pediatric Emergency Care

Volumn 22, Issue 12, 2006, Pages 782-785

  Ruha, Anne Michelle ^a,b,d   Yarema, Mark C ^c,d  

^a BANNER GOOD SAMARITAN MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d Calgary Health Region ^*  (United States)

Author keywords

Benzodiazepines; Haloperidol; Methamphetamine; Poisoning

Indexed keywords

BENZODIAZEPINE DERIVATIVE; DIAZEPAM; HALOPERIDOL; LORAZEPAM; METHAMPHETAMINE; MIDAZOLAM; PROPOFOL; VECURONIUM;

ACUTE METHAMPHETAMINE TOXICITY; AGITATION; ASPIRATION; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DYSTONIA; HEART ARRHYTHMIA; HOSPITAL ADMISSION; HUMAN; INFANT; INTENSIVE CARE UNIT; INTOXICATION; INTUBATION; LABORATORY TEST; MEDICAL RECORD; QT PROLONGATION; RESPIRATION DEPRESSION; RETROSPECTIVE STUDY; REVIEW; SEDATION; TORSADE DES POINTES; TREATMENT OUTCOME;

BENZODIAZEPINES; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD, PRESCHOOL; HALOPERIDOL; HUMANS; INFANT; METHAMPHETAMINE; NEUROTOXICITY SYNDROMES; RETROSPECTIVE STUDIES;

EID: 33846029876     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pec.0000245179.51535.ab     Document Type: Review

References (12)

1. Roberts D. The DAWN report: amphetamine and methamphetamine ED visits, 1995-2002. Available at: http://dawninfo.samhsa.gov/pubs_94_02/ shortreports/files/DAWN_tdr_amphetamine.pdf. Accessed October 28, 2004.
2. Watson W, Litovitz T, Klein-Schwartz W, et al. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med. 2004;22:335-404.
3. Derlet R, Rice P, Horowitz B, et al. Amphetamine toxicity: experience with 127 cases. J Emerg Med. 1989;7:157-161.
4. Thomas H, Schwartz E, Petrilli R. Droperidol versus haloperidol for chemical restraint of agitated and combative patients. Ann Emerg Med. 1992;21:407-413.
5. Richards J, Derlet R, Duncan D. Methamphetamine toxicity: treatment with a benzodiazepine versus a butyrophenone. Eur J Emerg Med. 1997;4:130-135.
6. Snyder S. Catecholamines in the brain as mediators of amphetamine psychosis. Arch Gen Psychiatry. 1972;27:169-179.
7. Kolecki P. Inadvertent methamphetamine poisoning in pediatric patients. Pediatr Emerg Care. 1998;14:385-387.
8. Harrison A, Lugo R, Lee W, et al. The use of haloperidol in agitated critically ill children. Clin Pediatr. 2002;41:51-54.
9. Wilt J, Minnema A, Johnson R, et al. Torsade de pointes associated with the use of intravenous haloperidol. Ann Intern Med. 1993;119:391-394.
10. Metzger E, Friedman R. Prolongation of the corrected QT and torsade de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill. J Clin Psychopharmacol. 1993;13:128-132.
11. Greenblatt D, Gross P, Harris J. Fatal hyperthermia following haloperidol therapy of sedative-hypnotic withdrawal. J Clin Psychiatry. 1978;39:673-675.
12. Witkin J, Goldberg S, Katz J. Lethal effects of cocaine are reduced by the dopamine-1 receptor antagonist sch 23390 but not by haloperidol. Life Sci. 1989;44:1285-1291.